Squarepoint’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$555K Buy
28,345
+13,485
+91% +$330K ﹤0.01% 3254
2025
Q4
$398K Sell
14,860
-34,450
-70% -$887K ﹤0.01% 3392
2025
Q3
$1.31M Buy
49,310
+26,284
+114% +$679K ﹤0.01% 2444
2025
Q2
$529K Sell
23,026
-46,744
-67% -$1.16M ﹤0.01% 3222
2025
Q1
$2.02M Buy
69,770
+52,106
+295% +$1.66M ﹤0.01% 2084
2024
Q4
$656K Buy
17,664
+11,929
+208% +$545K ﹤0.01% 3478
2024
Q3
$278K Sell
5,735
-84,817
-94% -$3.72M ﹤0.01% 3503
2024
Q2
$3.62M Buy
90,552
+8,501
+10% +$352K 0.01% 1600
2024
Q1
$3.6M Sell
82,051
-1,393
-2% -$71.9K 0.01% 1687
2023
Q4
$5.16M Sell
83,444
-18,058
-18% -$949K 0.02% 1379
2023
Q3
$4.67M Buy
101,502
+31,874
+46% +$1.74M 0.02% 1224
2023
Q2
$4M Buy
69,628
+58,372
+519% +$2.59M 0.02% 1209
2023
Q1
$422K Sell
11,256
-4,197
-27% -$138K ﹤0.01% 2394
2022
Q4
$433K Buy
+15,453
New +$449K ﹤0.01% 2363
2022
Q2
Sell
-30,634
Closed -$1.1M 2853
2022
Q1
$1.1M Buy
+30,634
New +$869K 0.01% 1537
2021
Q3
Sell
-40,760
Closed -$822K 2871
2021
Q2
$822K Buy
+40,760
New +$768K 0.01% 1779
2021
Q1
Sell
-10,714
Closed -$215K 3070
2020
Q4
$215K Sell
10,714
-7,921
-43% -$154K ﹤0.01% 2455
2020
Q3
$349K Sell
18,635
-56,553
-75% -$1.14M 0.01% 1690
2020
Q2
$1.69M Buy
75,188
+46,550
+163% +$853K 0.03% 691
2020
Q1
$425K Sell
28,638
-73,001
-72% -$1.27M 0.01% 1124
2019
Q4
$1.96M Buy
101,639
+52,696
+108% +$1.01M 0.01% 916
2019
Q3
$971K Sell
48,943
-5,880
-11% -$122K 0.01% 1260
2019
Q2
$1.16M Buy
54,823
+33,161
+153% +$693K 0.01% 1181
2019
Q1
$443K Sell
21,662
-9,110
-30% -$204K ﹤0.01% 1552
2018
Q4
$612K Buy
+30,772
New +$607K 0.01% 1150
2018
Q2
Sell
-18,018
Closed -$338K 1727
2018
Q1
$338K Buy
+18,018
New +$339K 0.01% 1265
2016
Q4
Sell
-14,049
Closed -$267K 1746
2016
Q3
$267K Buy
+14,049
New +$255K 0.02% 781

Other funds holding AMPH